Forkhead box A2-mediated regulation of female-predominant expression of the mouse Cyp2b9 gene

Drug Metabolism and Disposition

Volumn 36, Issue 6, 2008, Pages 1080-1087

  Hashita, Tadahiro ^a   Sakuma, Tsutomu ^a   Akada, Mami ^a   Nakajima, Asuka ^a   Yamahara, Hirofumi ^a   Ito, Sumiyo ^a   Takesako, Hidekazu ^a   Nemoto, Nobuo ^a,b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2B9; HEPATOCYTE NUCLEAR FACTOR 3BETA; LUCIFERASE;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GENE EXPRESSION; GENE MUTATION; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEX DIFFERENCE;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BASE SEQUENCE; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, REPORTER; HEPATOCYTE NUCLEAR FACTOR 3-BETA; HEPATOCYTES; LIVER; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; SEX CHARACTERISTICS; STEROID HYDROXYLASES;

MUS;

EID: 44149115226     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.107.019729     Document Type: Article

References (29)

1. Argetsinger LS, Norsted G, Billestrup N, White MF, and Carter-Su C (1996) Growth hormone, interferon-, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling. J Biol Chem 271:29415-29421.
2. Delesque-Touchard N, Park SH, and Waxman DJ (2000) Synergistic action of hepatocyte nuclear factors 3 and 6 on CYP2C12 gene expression and suppression by growth hormone-activated STAT5b. J Biol Chem 275:34173-34182.
3. Dominici FP, Argentino DP, Munoz MC, Miquet JG, Sotelo AI, and Turyn D (2005) Influence of the crosstalk between growth hormone and insulin signaling on the modulation of insulin sensitivity. Growth Horm IGF Res 15:324-336.
4. Gandhi M, Aweeka F, Greenblatt RM, and Blaschke TF (2004) Sex difference in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol 44:499-523.
5. Gonzalez FJ (1991) Human cytochrome P450: possible roles of drug-metabolizing enzymes and polymorphic drug oxidation in addiction. NIDA Res Monogr 111:202-213.
6. Holloway MG, Cui Y, Laz EV, Hosui A, Hennighausen L, and Waxman DJ (2007) Loss of sexually dimorphic liver gene expression upon hepatocyte-specific deletion of Stat5a-Stat5b locus. Endocrinology 148:1977-1986.
7. Holloway MG, Laz EV, and Waxman DJ (2006) Codependence of growth hormone-responsive, sexually dimorphic hepatic gene expression on signal transducer and activator of transcription 5b and hepatic nuclear factor 4α. Mol Endocrinol 20:647-660.
8. Jarukamjorn K, Sakuma T, Jaruchotikamol A, Ishino Y, Oguro M, and Nemoto N (2006) Modified expression of cytochrome P450 mRNAs by growth hormone in mouse liver. Toxicology 219:97-105.
9. Jarukamjorn K, Sakuma T, and Nemoto N (2002) Sexual dimorphic expression of mouse hepatic CYP2B: alterations during development or after hypophysectomy. Biochem Pharmacol 63: 2037-2041.
10. Jover R, Bort R, Gómez-Lechón MJ, and Castell JV (2001) Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting. Hepatology 33:668-675.
11. Jürgens G, Lange KH, Reuther LO, Rasmussen BB, Brosen K, and Christensen HR (2002) Effect of growth hormone on hepatic cytochrome P450 activity in healthy elderly men. Clin Pharmacol Ther 71:162-168.
12. Lahuna O, Rastegar M, Maiter D, Thissen JP, Lemaigre FP, and Rousseau GG (2000) Involvement of STAT5b (signal transducer and activator of transcription 5) and HNF-4 (hepatocyte nuclear factor 4) in the transcriptional control of the hnf6 gene by growth hormone. Mol Endocrinol 14:285-294.
13. Lamba V, Lamba J, Yasuda K, Strom S, Davila J, Hancock ML, Fackenthal JD, Rogan PK, Ring B, Wrighton SA, et al. (2003) Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. J Pharmacol Exp Ther 307:906-922.
14. Liu F, Song YK, and Liu D (1999) Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Therapy 6:1258-1266.
15. MacLeod JN, Pampori NA, and Shapiro BH (1991) Sex differences in the ultradian pattern of plasma growth hormone concentrations in mice. J Endocrinol 131:395-399.
16. Nemoto N and Sakurai J (1995) Glucocorticoid and sex hormones as activating or modulating factors for expression of Cyp2b-9 and Cyp2b-10 in the mouse liver and hepatocytes. Arch Biochem Biophys 319:286-292.
17. Rausa FM, Tan Y, and Costa RH (2003) Association between hepatocyte nuclear factor 6 (HNF-6) and FoxA2 DNA binding domains stimulates FoxA2 transcriptional activity but inhibits HNF-6 DNA binding. Mol Cell Biol 23:437-449.
18. Sakuma T, Honma R, Maguchi S, Tamaki H, and Nemoto N (2001) Different expression of hepatic and renal cytochrome P450s between the streptozotocin-induced diabetic mouse and rat. Xenobiotica 31:223-237.
19. Sakuma T, Kitajima K, Nishiyama M, Mashino M, Hashita T, and Nemoto N (2004) Suppression of female-specific murine Cyp2b9 gene expression by growth or glucocorticoid hormones. Biochem Biophys Res Commun 323:776-781.
20. Souza SC, Frick PG, Yip R, Lobo RB, Tai LR, and Goodman HM (1994) Growth hormone stimulates tyrosine phosphorylation of insulin receptor substrate-1. J Biol Chem 269:30085-30088.
21. Spear BT, Jin L, Ramasamy S, and Dobierzewska A (2006) Transcriptional control in the mammalian liver: liver development, perinatal repression, and zonal gene regulation. Cell Mol Life Sci 63:2922-2938.
22. Thirone ACP, Carvalho CRO, and Saad MJA (1999) Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and SHC in rat tissues. Endocrinology 140:55-62.
23. Watkins PB, Murray SA, Winkelman LG, Heuman DM, Wrighton SA, and Guzelian PS (1989) Erythromycin breath test as an assay of glucocorticoid-inducible liver P-450. J Clin Invest 83:688-697.
24. Waxman DJ and O'Connor C (2006) Growth hormone regulation of sex-dependent liver gene expression. Mol Endocrinol 20:2613-2629.
25. Wiwi CA, Gupte M, and Waxman DJ (2004) Sexually dimorphic P450 gene expression in liver-specific hepatocyte nuclear factor 4α-deficient mice. Mol Endocrinol 18:1975-1987.
26. Wolbold R, Klein K, Burk O, Nussler AK, Neuhaus P, Eichelbaum M, Schwab M, and Zanger UM (2003) Sex is a major determinant of CYP3A4 expression in human liver. Hepatology 38:978-988.
27. Wolfrum C, Asilmaz E, Luca E, Friedman JM, and Stoffel M (2004) FoxA2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 432:1027-1032.
28. Wolfrum C, Besser D, Luca E, and Stoffel M (2003) Insulin regulates the activity of forkhead transcription factor Hnf-3β/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization. Proc Natl Acad Sci U S A 100:11624-11629.
29. Yamauchi T, Kaburagi Y, Ueki K, Tsuji Y, Stark GR, Kerr IM, Tsushima T, Akanuma Y, Komuro I, Tobe K, et al. (1998) Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2 and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase) and concomitantly PI3-kinase activation via JAK2 kinase. J Biol Chem 273:15719-15726.